At present, the potential mechanisms of SJS/TEN induced by immunotherapy include: (a) excessive activation of T lymphocytes; (b) increase of inflammatory factors (such as TNF-α); (c) exposure of cross antigens (Basketter and Kimber, 2018). The gene discussed is TNF; the disease is toxic epidermal necrolysis.